PRESS-RELEASE ·Filed May 11, 2026
Press release · Earnings
Final — all horizons settled through T+60d
CLRB ▼ -17.65% at T+60d
NEUTRAL call -17.65% · α vs SPY -22.04% · entry $3.06 → $2.52
T+1d
-4.58%
call -4.58% · α -4.44%
$2.92
settled 6mo ago
T+5d
+2.61%
call +2.61% · α +2.70%
$3.14
settled 5mo ago
T+20d
-22.88%
call -22.88% · α -22.57%
$2.36
settled 5mo ago
T+60d
-17.65%
call -17.65% · α -22.04%
$2.52
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Cellectar Biosciences, Inc. announced it will report its Q1 results on May 14, 2026.
Key Facts
- Cellectar Biosciences, Inc. announced it will report its Q1 results on May 14, 2026.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291850 |
17 reports for CLRB
63% Hit rate @ T+60 Went positive at some point 6 of 9 best @ T+60▲ +27.20%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $1.19 | awaiting T+60 | — | $1.22 (+2.52%) |
Aug 13, 2026 10w ago | 8-K | $2.48 | awaiting T+60 | — | $1.22 (−50.81%) |
Aug 13, 2026 10w ago | Press Release | $2.48 | awaiting T+60 | — | $1.22 (−50.81%) |
Jun 1, 2026 21w ago | Press Release | $2.97 $2.54 | ▼ −14.48% | ▼ −15.71% | $1.22 (−58.92%) |
May 29, 2026 21w ago | S-1/A | $3.14 $2.52 | ▲ +19.75% | ▲ +20.93% | $1.22 (+61.15%) |
May 28, 2026 21w ago | DEFA14A | $3.14 $2.52 | ▼ −19.75% | ▼ −20.93% | $1.22 (−61.15%) |
May 19, 2026 22w ago | S-1 | $3.17 $2.60 | ▲ +17.98% | ▲ +22.98% | $1.22 (+61.51%) |
May 14, 2026 23w ago | 8-K | $3.20 $2.60 | ▼ −18.75% | ▼ −22.34% | $1.22 (−61.87%) |
May 14, 2026 23w ago | Press Release | $3.20 $2.60 | ▼ −18.75% | ▼ −22.34% | $1.22 (−61.87%) |
May 11, 2026 24w ago | Press Release | $3.06 $2.52 | ▼ −17.65% | ▼ −22.04% | $1.22 (−60.13%) |
Showing 10 of 17
US Market Status
Market Closed — Opens in 22m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers